LIVING RESOURCE

Advancing digital health through a library of clinical trial endpoints

The Library of Digital Endpoints by the Digital Health Measurement Collaborative Community (DATAcc) by the Digital Medicine Society (DiMe) is the only library specifically focused on industry-sponsored studies of new medical products or applications.

The library is a living resource that is continuously updated, intended to be both a reference resource and a transparent library the community helps build and maintain. It benchmarks progress in the field and highlights the work we must continue to do to advance the use of digital endpoints to speed medical product development.

ACCESSED OVER

14,000 times

Digital endpoints are used across development stages

TRIAL PHASES

Digital endpoints are used for development of many product types

INVESTIGATIONAL PRODUCT

Industry sponsors trust digital endpoints & are putting them to use

ENDPOINT POSITIONING

LIBRARY

Contribute to the Library

The Library uses rigorous eligibility criteria, including registration in a public clinical trials registry, industry funding, an interventional design, and at least one safety or efficacy endpoint captured by a sensor-based digital health technology.

*The library is a living, dynamic resource that is updated periodically. Last update: November 2024. Next update: April 2026.

Want the full dataset?

Download the Library as a CSV to filter, sort, and analyze the data directly.

The sponsors using digital endpoints

Primary, secondary or other/exploratory

Contribute to the Library of Digital Endpoints

Is your company’s work missing? Keep the Library of Digital Endpoints up-to-date by submitting your digital endpoints for more transparency, clarity, and solutions to progress in our field.

81 Sponsors have collected 505 digital endpoints

Add your work

Library methodology & eligibility

Methodology

Endpoints are identified for inclusion in the library from one of two sources:

DATAcc completes a periodic search of clinicaltrials.gov.
DATAcc reviews the eligibility of crowdsourced submissions.

Eligibility

Endpoints are eligible for inclusion if they meet the following criteria:

The trial is listed on a reputable registry.
The trial is industry-funded.
The trial assesses a regulated intervention designed for screening, diagnosis, treatment, or disease prevention.
The trial includes one or more safety and/or efficacy/effectiveness endpoints captured by a sensor-based digital health technology product.

Download the full methodology & eligibility overview

Have you heard about the sDHT Adoption Navigator?

The sDHT Adoption Navigator is your companion for building or adopting sensor-based digital health technologies (sDHTs) in clinical trials for medical product development, including:

The Roadmap | An interactive guide for developers & adopters navigating sDHT endpoint strategy and implementation
The Library | Vetted resources for sDHT development & clinical trial use, featuring NaVi your AI-powered research assistant

Go to the Navigator